Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Wegovy and Ozempic top list of 15 drugs up for next price negotiations
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of federal price negotiations, which are scheduled to begin this year, with resulting bargained prices going into effect in 2027.
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...
Jan. 17, 2025 – Medicare will negotiate the prices of weight loss drugs Wegovy and Ozempic with drug companies, a move that could create big savings for seniors who take the drugs, the Biden ...
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...
WASHINGTON — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback